Drug
Peginesatide clinical trials
Also written Hematide and AF37702.
- studies test it
- 20
- open now
- 0
- in phase 3
- 5
- first study started
- 2004
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2006 (5)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 11
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 20 · Other 0
Affymax (13) · Takeda (5) · Vifor Fresenius Medical Care Renal Pharma (1) · Amgen (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses peginesatide is read from its arms, and is right about nine times in ten.
Testing it · 20
- Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) TrialTerminatedNot applicableVifor Fresenius Medical Care Renal PharmaNCT03214627Written as Erythropoiesis-Stimulating Agent (ESA)
- Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCompletedPhase 2TakedaNCT00314795Written as Peginesatide
- Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedPhase 3TakedaNCT01478971Written as Peginesatide
- Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving HemodialysisTerminatedPhase 4AmgenNCT01737879Written as Peginesatide
- Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedPhase 3AffymaxNCT00597584Written as peginesatide
- Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedPhase 3AffymaxNCT00598273Written as peginesatide
- Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedPhase 3AffymaxNCT00598442Written as peginesatide
- Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedPhase 3AffymaxNCT00597753Written as peginesatide
- Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving ChemotherapyCompletedPhase 2AffymaxNCT00272662Written as peginesatide
- Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease PatientsCompletedPhase 2AffymaxNCT00228436Written as peginesatide
- Peginesatide for Anemia in Chronic Hemodialysis PatientsCompletedPhase 2AffymaxNCT00228449Written as peginesatide
- Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy VolunteersCompletedPhase 1AffymaxNCT00097747Written as peginesatide
- Safety of Single Doses of Peginesatide in Patients With Chronic Kidney DiseaseTerminatedPhase 2AffymaxNCT00109291Written as peginesatide
- Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.CompletedPhase 2TakedaNCT00752791Written as Peginesatide
- Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.CompletedPhase 2TakedaNCT00752609Written as Peginesatide
- Peginesatide for Maintenance Treatment of Anemia in Participants on HemodialysisCompletedPhase 2AffymaxNCT00434330Written as peginesatide
- Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESACompletedPhase 2AffymaxNCT00680043Written as peginesatide
- Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)TerminatedPhase 2AffymaxNCT00453973Written as peginesatide
- Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKDTerminatedPhase 2AffymaxNCT00372489Written as peginesatide
- A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.TerminatedPhase 1TakedaNCT00629876Written as Peginesatide
As the comparator · 1 — what is tested is compared with peginesatide
Codes
What other systems call peginesatide · ClinicalTrials.gg INT005783
- MeSH (NLM) C556270peginesatideOne source NLM
- UNII (FDA) JX56W9N61QPEGINESATIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1248798Confirmed FDA, Wikidata
- Wikidata Q3662569peginesatideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48422PeginesatideOne source FDA
- DrugBank DB08894One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C556270 | peginesatide | One source NLM |
| UNII (FDA) | JX56W9N61Q | PEGINESATIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1248798 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3662569 | peginesatide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48422 | Peginesatide | One source FDA |
| DrugBank | DB08894 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.